DDI-DrugBank.d753.s0 >> The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects. >> 29-43,55-63,66-74,77-89,100-110,113-126,135-141,144-168,171-204,211-217
DDI-DrugBank.d753.s1 >> When such combined therapy is contemplated, the dose of one or both agents should be reduced.
DDI-DrugBank.d753.s2 >> Anticholinergics or other medications with anticholinergic activity when used concurrently with opioid analgesics may result in increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus. >> 0-15,96-112
DDI-DrugBank.d753.s3 >> It has been reported that the incidence of bradycardia was increased when oxymorphone was combined with propofol for induction of anesthesia. >> 74-84,104-111
DDI-DrugBank.d753.s4 >> In addition, CNS toxicity has been reported (confusion, disorientation, respiratory depression, apnea, seizures) following coadministration of cimetidine with opioid analgesics; >> 143-152,159-175
DDI-DrugBank.d753.s5 >> no clear-cut cause and effect relationship was established.
